AlphaGen Therapeutics
Develops targeted radioligand therapies (RLTs) to improve cancer treatment globally.
Develops targeted radioligand therapies (RLTs) to improve cancer treatment globally.
Sector
Life SciencesCategory
TherapeuticsLocation
Shanghai, ChinaInitial Investment
2023
AlphaGen Therapeutics is a radiopharmaceutical company focused on the discovery, development and commercialization of innovative targeted radioligand therapies (RLTs). Leveraging its cutting-edge technology platform, the company aims to develop targeted RLTs for patients in China and around the world.